Concepedia

Mandy van Gulijk

MV

6

Publications

877

Citations

6

H-Index

2018

Active since

Affiliations

Leiden University Medical Center(Current)

Oncode Institute

Erasmus MC

Erasmus MC Cancer Institute

Mandy van Gulijk is an author at Leiden University Medical Center specializing in t cell immunity, cell biology, and tumor immunity.

ORCID

Top concepts

Publications per year

2018–2023

6

Publications

6

The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes

Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder et al. · Cancer Cell · 2020 · 626 citations · Full text

, , +7

PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance

Mandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters et al. · Science Immunology · 2023 · 93 citations · Full text

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

Sai Ping Lau, Nadine van Montfoort, Priscilla Kinderman et al. · Journal for ImmunoTherapy of Cancer · 2020 · 60 citations · Full text

<scp>NKG2A</scp> is a late immune checkpoint on <scp>CD8</scp> T cells and marks repeated stimulation and cell division

Linda Borst, Marjolein Sluijter, Gregor Sturm et al. · International Journal of Cancer · 2021 · 53 citations · Full text

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response

Floris Dammeijer, Cornedine J. de Gooijer, Mandy van Gulijk et al. · EBioMedicine · 2021 · 26 citations · Full text

Rows per page

1–5 of 6